Merck & Co., Inc. (MRK) Financials

MRK Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 128.7 billion 82.8 billion
Dec. 31, 2025 136.9 billion 84.2 billion
Sept. 30, 2025 129.5 billion 77.6 billion
June 30, 2025 117.5 billion 68.5 billion

MRK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 2.9 billion 185.0 million
Dec. 31, 2025 1.8 billion 205.0 million
Sept. 30, 2025 6.8 billion 204.0 million
June 30, 2025 2.5 billion 216.0 million

MRK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -4.2 billion
Dec. 31, 2025 3.0 billion
Sept. 30, 2025 5.8 billion
June 30, 2025 4.4 billion

MRK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 5.7 billion 46.7 billion -
Dec. 31, 2025 14.6 billion 46.8 billion 901.0 million
Sept. 30, 2025 18.2 billion 40.0 billion -
June 30, 2025 8.6 billion 34.0 billion -

MRK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 2.5 billion
Dec. 31, 2025 2.5 billion
Sept. 30, 2025 2.5 billion
June 30, 2025 2.5 billion

MRK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 991.0 million 12.6 billion 2.7 billion -
Dec. 31, 2025 1.0 billion 2.5 billion 2.8 billion -
Sept. 30, 2025 987.0 million 3.6 billion 2.0 billion -
June 30, 2025 764.0 million 3.5 billion 2.1 billion -

MRK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 16.3 billion 2.9 billion
Dec. 31, 2025 16.3 billion 4.8 billion
Sept. 30, 2025 17.2 billion 4.2 billion
June 30, 2025 15.8 billion 3.8 billion

MRK Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRK

List: Contenders

Price: $125.20

52 week price:
76.66
130.29

Dividend Yield: 2.65%

5-year range yield:
2.45%
4.25%

Forward Dividend Yield: 2.72%

Payout Ratio: 57.04%

Payout Ratio Range:
-2291.07%
397.66%

Dividend Per Share: 3.40 USD

Earnings Per Share: 3.55 USD

P/E Ratio: 31.99

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 7.8 million

Ebitda: 2.3 billion

Market Capitalization: 313.1 billion

Average Dividend Frequency: 4

Years Paying Dividends: 65

DGR3: 5.57%

DGR5: 7.12%

DGR10: 6.54%

DGR20: 4.11%

Links: